Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs >

Tekmira Pharmaceuticals Corporation (TKMR)

Add TKMR Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Tonyeight, nanopatent, stock_MD, KarinCA, [SMART MONEY] , baseball74
Search This Board:
Last Post: 9/1/2014 11:00:12 PM - Followers: 107 - Board type: Free - Posts Today: 0

Tekmira Pharmaceuticals Corporation








Company Information:

100 - 8900 Glenlyon Parkway
Burnaby, British Columbia
Canada V5J 5J8

Telephone: 604.419.3200
Fax: 604.419.3201


As the fields of genetics, medicine and therapeutics continue to converge, the management of illness at its genetic source by silencing genes via RNA interference (RNAi) holds the very real potential to revolutionize treatment on a scale not seen in decades. Tekmira is one of a handful of biotech companies around the world working to exploit the potential of RNAi to treat disease. And it is from among these unique companies that the next wave of therapeutic breakthroughs will emerge.

 Tekmira is uniquely equipped to become a leading force in the field. Guided by a cohesive vision, the company possesses leading technology capabilities and a solid intellectual property portfolio in the area of lipid-based nucleic acid delivery, known as SNALP (Stable Nucleic Acid Lipid Particles) to deliver siRNAs (small interfering RNAs) as well as other oligonucleotides in the treatment of disease.

With one RNAi drug candidate in clinical development and another in late preclinical development,  plus a pipeline of up to five additional targets made possible through an agreement with RNAi leader Alnylam, Tekmira is well positioned to aggressively advance its product development strategy. In addition to Alnylam, Roche, Merck and Regulus all have access to Tekmira's technology in the delivery of siRNAs and microRNAs.

Finally, broad manufacturing capabilities and a strong capital position permit the company to move forward decisively and build a solid base for both near and longer term growth.




Important Company Highlights: 

Tekmira's siRNA delivery technology platform is termed SNALP for "stable nucleic acid-lipid particles". SNALP are specialized lipid nanoparticles that fully encapsulate and systemically deliver a variety of nucleic acid molecules such as siRNA. Pre-clinical studies have shown them to be effective in delivering the drug to target organs and into cells where the nucleic acid-based drug can carry out its desired effect while minimizing systemic toxicity.

SNALP technology relies on something called the "enhanced permeability and retention effect", which occurs because these nucleic acid-containing particles have a long circulation time in the blood, resulting in increased accumulation at sites of vascular leak such as those found at sites of tumor cell growth, infection or inflammation. Once at the target site, cells take up the SNALP through endocytosis and the nucleic acid payload is delivered inside the cell resulting in unparalleled potency.





Recent News:





Links of importance for those that trade Canadian stocks:




 CNW Group Newswire:

Canadian Insider:

Currency Converter:


Transfer Agent:

CIBC Mellon Trust,
Suite 1600, The Oceanic Plaza,
1066 West Hastings Street,
Vancouver, BC V6E 3X1

Share Structure:   See filings

Investor Relations:

Ian Mortimer
Executive Vice President, Finance and Chief Financial Officer
Telephone: 604.419.3200
Fax: 604.419.3201

Adam Peeler
Investor Relations
The Equicom Group
Telephone: 416.815.0700 x 225 


CHART is for Canadian ticker.  Remember to adjust for exchange rate.

Currency Converter:




 All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
Option Chain for TKMR
TKMR News: Current Report Filing (8-k) 08/26/2014 02:48:37 PM
TKMR News: Current Report Filing (8-k) 08/20/2014 02:00:59 PM
TKMR News: Quarterly Report (10-q) 08/14/2014 04:50:26 PM
TKMR News: Current Report Filing (8-k) 08/08/2014 06:02:07 AM
TKMR News: Current Report Filing (8-k) 08/08/2014 06:02:07 AM
#2246  Sticky Note Tekmira Pharmaceuticals Corp. Is More Than Just A kei 08/27/14 04:53:01 PM
#1088  Sticky Note TKMR – Tekmira Pharmaceuticals Corp News, Filings and misc: KarinCA 08/10/14 01:52:25 AM
#1081  Sticky Note FDA ALLOWS limited USE OF EBOLA DRUG... [SMART MONEY] 08/09/14 11:44:12 PM
#961  Sticky Note For the studious - this is very detailed nanopatent 08/08/14 05:18:35 PM
#2381   Poor response to Ebola causing needless deaths: World Echo20 09/01/14 11:00:12 PM
#2380   Another trial, testing a combination of different compounds[/quote nanopatent 09/01/14 04:09:06 PM
#2379   Much buckeroooo $ coming Tonyeight 09/01/14 03:46:55 PM
#2378   TKMR 21.4 $22.2 on vol will bust this spades 09/01/14 10:09:34 AM
#2377   Splinter Cell Echo20 09/01/14 07:35:49 AM
#2376   it might be confidential but if it's not Splinter_Cell 09/01/14 02:40:49 AM
#2375   Splinter Cell Echo20 08/31/14 10:18:41 PM
#2374   there might be a case in Stockholm its Splinter_Cell 08/31/14 04:38:41 PM
#2373   I have no idea how TKM-Ebola is made nanopatent 08/31/14 02:59:34 PM
#2372   I believe that if the price per share Splinter_Cell 08/31/14 02:16:55 PM
#2371   Splinter cell Tkmr Ebola to the rescue, If enough can Echo20 08/31/14 02:12:04 PM
#2370   omg I hope it won't get to EU Splinter_Cell 08/31/14 05:54:42 AM
#2369 Tonyeight 08/31/14 12:01:14 AM
#2368   The Washington Post: It was already the worst kei 08/30/14 09:52:09 PM
#2367   Thirty US states ask CDC for more information Echo20 08/30/14 11:39:11 AM
#2366   West Africa Ebola outbreak could infect 20,000 people, kei 08/30/14 11:28:45 AM
#2365   imo, should test those two (especially TKMR's one)..i'm kei 08/30/14 11:02:30 AM
#2364   I'd be more impressed if the optimized treatment KarinCA 08/30/14 08:32:30 AM
#2363   Less to zMapp 5-days article that meets the eye Cave In Temptor 08/30/14 07:02:31 AM
#2362   Anyone have any idea how much one Echo20 08/30/14 12:03:02 AM
#2361 Tonyeight 08/29/14 10:40:20 PM
#2360   Could happen, never know. I believe it will BoilerRoom 08/29/14 10:26:28 PM
#2359   pass over 25 coming wk and Tonyeight 08/29/14 10:23:43 PM
#2357   Thanks Tony, I'm not worried at all here... BoilerRoom 08/29/14 10:12:10 PM
#2356   do not worry 25 up coming month$ Tonyeight 08/29/14 10:05:42 PM
#2355   no problem to hit 25 up Tonyeight 08/29/14 10:01:05 PM
#2354   i know that =just put other artical ok bro. Tonyeight 08/29/14 09:59:19 PM
#2353   TKMR we should hit $25.00 next week... BoilerRoom 08/29/14 09:55:35 PM
#2352   yes. we got the back of the DoD.. IMHO. Splinter_Cell 08/29/14 09:54:10 PM
#2351   This isn't Zmapp... Our treatment is better BoilerRoom 08/29/14 09:41:35 PM
#2350   hoping =heads up for tkmr coming wks $+ Tonyeight 08/29/14 07:49:20 PM
#2349 Tonyeight 08/29/14 07:40:54 PM
#2348   ZMapp Reverses Ebola Infection in Animal Testing Tonyeight 08/29/14 07:40:05 PM
#2347 Tonyeight 08/29/14 07:10:59 PM
#2346   “It’s important to remain cautious because there are nanopatent 08/29/14 04:58:58 PM
#2345   This probably why TKMR is moving up after hours. KarinCA 08/29/14 04:56:09 PM
#2344   Great news as INSERM is a French equivalent Cave In Temptor 08/29/14 04:19:26 PM
#2343   Inserm is considering two trials, each involving at nanopatent 08/29/14 04:16:24 PM
#2342   France’s Inserm in Talks With Guinea on Ebola Trials nanopatent 08/29/14 03:58:27 PM
#2341 ivanv 08/29/14 02:20:16 PM
#2340   And to think it all originated in a nanopatent 08/29/14 11:58:07 AM
#2339   Yup, I think we will see that after ivanv 08/29/14 11:14:27 AM
#2338   red to green is not out of the Mungyboy 08/29/14 11:10:28 AM
#2337   ~ you're most welcome karin and thank you kei 08/29/14 09:46:15 AM
#2336   Nanopatent Very in Echo20 08/29/14 07:43:55 AM
#2334   Thanks for posting that kei. ;) KarinCA 08/29/14 01:08:48 AM
#2333   yes sir very costly >>>>> Tonyeight 08/28/14 10:57:27 PM
#2332   Cost to control Ebola shoots up nanopatent 08/28/14 08:56:01 PM
#2331   Tekmira looks to have a definite and effective remedy. nanopatent 08/28/14 08:43:04 PM
#2330   Yup, This outbreak is worse then they expected. BoilerRoom 08/28/14 08:16:41 PM